ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,842.91
0.11%
US Tech 100
20,203.20
0.00%
다우존스 지수
42,518.28
0.52%
Bitcoin
97,308.07
0.83%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. USOTC

  6. BioCorRx Inc (QB) (BICX) 시세

BioCorRx Inc (QB)

BioCorRx Inc (QB) (BICX)

USOTC
0.43
0.02
(4.88%)
마감 15 1월 6:00AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
0.43
매수가
0.38
매도가
0.49
거래량
3,580
0.38 일간 변동폭 0.4675
0.282 52주 범위 1.50
market_cap
5.482M
전일 종가
0.41
개장가
0.38
최근 거래 시간
413
@
0.43
마지막 거래 시간
재정 규모
US$ 1,474
VWAP
0.411769
평균 볼륨(3m)
3,730
발행 주식
12,748,896
배당수익률
-
주가수익률
-1.46
주당순이익(EPS)
-0.3
매출
89k
순이익
-3.77M

BioCorRx Inc (QB) 정보

BioCorRx Inc., through its subsidiaries, develops and provides innovative treatment programs for substance use and other related disorders. The Beat Addiction Recovery Program is a medication-assisted treatment (MAT) program for substance use disorder that includes peer recovery support. The UnCrave... BioCorRx Inc., through its subsidiaries, develops and provides innovative treatment programs for substance use and other related disorders. The Beat Addiction Recovery Program is a medication-assisted treatment (MAT) program for substance use disorder that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application. The Company's majority owned subsidiary BioCorRx Pharmaceuticals Inc. is also engaged in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. Specifically, the Company is developing an implantable naltrexone (BICX104) with the goal of future regulatory approval with the Food and Drug Administration. For more information on BICX, visit www.BioCorRx.com. 더 보기

섹터
Spec Outpatient Facility,nec
산업
Spec Outpatient Facility,nec
웹사이트
www.biocorrx.com
본부
Reno, Nevada, USA
설립됨
-
BioCorRx Inc (QB) is listed in the Spec Outpatient Facility sector of the OTC 시장 with ticker BICX. The last closing price for BioCorRx (QB) was US$0.41. Over the last year, BioCorRx (QB) shares have traded in a share price range of US$ 0.282 to US$ 1.50.

BioCorRx (QB) currently has 12,748,896 shares in issue. The market capitalisation of BioCorRx (QB) is US$5.23 million. BioCorRx (QB) has a price to earnings ratio (PE ratio) of -1.46.

BICX 최신 뉴스

추가 뉴스

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

14 11월 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

14 8월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

11 7월 2024
Edgar (US Regulatory)

Form 8-K - Current report

10 7월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

09 7월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

09 7월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

04 6월 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

16 5월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

08 3월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 1월 2024
Edgar (US Regulatory)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000.4675000CS
40.00751.775147928990.42250.46750.3725900.40008962CS
120.1343.33333333330.30.50.337300.36721234CS
26-0.06-12.24489795920.490.534380.28226690.36921715CS
52-0.27-38.57142857140.71.50.28221200.56535813CS
156-3.83-89.90610328644.264.510.217720701.51260292CS
260-2.51-85.37414965992.948.10.15522672.26545711CS

BICX - Frequently Asked Questions (FAQ)

What is the current BioCorRx (QB) share price?
The current share price of BioCorRx (QB) is US$ 0.43
How many BioCorRx (QB) shares are in issue?
BioCorRx (QB) has 12,748,896 shares in issue
What is the market cap of BioCorRx (QB)?
The market capitalisation of BioCorRx (QB) is USD 5.23M
What is the 1 year trading range for BioCorRx (QB) share price?
BioCorRx (QB) has traded in the range of US$ 0.282 to US$ 1.50 during the past year
What is the PE ratio of BioCorRx (QB)?
The price to earnings ratio of BioCorRx (QB) is -1.46
What is the cash to sales ratio of BioCorRx (QB)?
The cash to sales ratio of BioCorRx (QB) is 61.43
What is the reporting currency for BioCorRx (QB)?
BioCorRx (QB) reports financial results in USD
What is the latest annual turnover for BioCorRx (QB)?
The latest annual turnover of BioCorRx (QB) is USD 89k
What is the latest annual profit for BioCorRx (QB)?
The latest annual profit of BioCorRx (QB) is USD -3.77M
What is the registered address of BioCorRx (QB)?
The registered address for BioCorRx (QB) is 401 RYLAND ST, STE 200-A, RENO, NEVADA, 89502
What is the BioCorRx (QB) website address?
The website address for BioCorRx (QB) is www.biocorrx.com
Which industry sector does BioCorRx (QB) operate in?
BioCorRx (QB) operates in the SPEC OUTPATIENT FACILITY,NEC sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
RDRSFRDARS Inc (CE)
US$ 0.001
(99,900.00%)
2.08k
DMTKQDermTech Inc (CE)
US$ 0.0005
(49,900.00%)
2k
COUVCorporate Universe Inc (CE)
US$ 0.0001
(9,900.00%)
2k
RQHTFReliq Health Technologies Inc (CE)
US$ 0.01
(9,900.00%)
63.14k
CLTHClean Tech Biofuels Inc (CE)
US$ 0.0001
(9,900.00%)
1,000
BLIBQBB Liquidating Inc (CE)
US$ 0.000001
(-99.99%)
21.08k
FLESAuto Parts 4Less Group Inc (CE)
US$ 0.000001
(-99.50%)
2.5M
DNAXDNA Brands Inc (PK)
US$ 0.000001
(-99.50%)
12.3M
FBECFBEC Worldwide Inc (CE)
US$ 0.000001
(-99.50%)
130k
CCTLCoin Citadel (PK)
US$ 0.000001
(-99.50%)
1.25k
TONRTonner One World Holdings Inc (PK)
US$ 0.0002
(0.00%)
331.58M
PHILPHI Group Inc (PK)
US$ 0.0002
(-33.33%)
292.68M
RDARRaadr Inc (PK)
US$ 0.00115
(-4.17%)
257.02M
TSOITherapeutic Solutions International Inc (PK)
US$ 0.0002
(0.00%)
253.17M
HMBLHUMBL Inc (PK)
US$ 0.001
(11.11%)
232.5M

BICX Discussion

게시물 보기
JB51 JB51 10 월 전
Can’t hurt, stocks went nowhere! Still don’t understand why it’s taking so long, what happened to Fast Track??
👍️0
big orange big orange 10 월 전
anybody have confidence in the new CEO?
👍️0
JB51 JB51 12 월 전
I think it got lost, can’t find the Track !
This is so needed, but taking for ever and it’s all about the delivery, not the drug
👍️0
big orange big orange 12 월 전
what happened to the fast track response?
👍️0
Nathan123456 Nathan123456 1 년 전
Damn I was dead on
👍️0
RB10 RB10 1 년 전
Are we in bankruptcy court yet?
👍️0
Nathan123456 Nathan123456 1 년 전
Brady take his paid vacation before he steps down from CEO?
👍️0
Nathan123456 Nathan123456 1 년 전
Who the F*** would sell when we are just waiting ond the fast track response and should have it within 60days
👍️0
Nathan123456 Nathan123456 2 년 전
Ended up with way more buys than sells just didn't move us out of the red for whatever reason
👍️0
JB51 JB51 2 년 전
Someone must know something
👍️0
Nathan123456 Nathan123456 2 년 전
I miss something?
👍️0
74 74 3 년 전
https://seekingalpha.com/news/3827831-biocorrx-starts-recruiting-in-trial-of-biodegradable-naltrexone-pellet-bicx104-for-opioid-disorder
👍️0
74 74 3 년 전
https://www.globenewswire.com/news-release/2022/02/14/2384416/0/en/BioCorRx-Announces-Orange-County-Research-Center-as-Clinical-Trial-Site-for-First-In-Human-Clinical-Trial-of-BICX104.html
👍️0
Nathans123 Nathans123 3 년 전
Has phase 1 of the clinical trials started yet???
👍️0
74 74 3 년 전
https://www.ocregister.com/2021/10/20/addiction-anaheim-firm-to-test-implant-that-blunts-a-drug-users-high
👍️0
Nathans123 Nathans123 3 년 전
Whats next? When should we expect news next?
👍️0
Admtiger Admtiger 4 년 전
If there are not enough funds hopefully they are not running the price up just to make an offering.
👍️0
Nathans123 Nathans123 4 년 전
Not enough funds to finish trials? What about the grants? Oh well someone will buy them out !!!!
👍️0
JB51 JB51 4 년 전
Hopefully you’re right
👍️0
DREAM BIG DREAM BIG 4 년 전
Huge Buy out !
👍️0
JB51 JB51 4 년 전
Enlighten us
👍️0
DREAM BIG DREAM BIG 4 년 전
If what I am thinking is right .. we could see $20 very soon !
👍️0
Nathans123 Nathans123 4 년 전
Looks like them $9's got chewed up 10mins after close..
👍️0
JB51 JB51 4 년 전
Must be big news coming
👍️0
thejourneyman thejourneyman 4 년 전
NICE BUMP TODAY !!!!
What's going on????????
👍️0
Nathan123456 Nathan123456 4 년 전
I was thinking we would have made some money today... Guess not
👍️0
thejourneyman thejourneyman 4 년 전
IND SUBMISSION !!!!!

https://www.biocorrx.com/news-media/press-releases/detail/179/biocorrx-announces-submission-of-ind-application-to-the-fda
👍️0
Nathans123 Nathans123 4 년 전
Nathan, it’s an IND. Pre-IND was done long time ago. That said it’s a tedious process to compile all of the documents and requires a lot of QC review. As noted in PR, we rely on many 3rd parties to get it all together.
4:35 PM · Mar 19, 2021 from Los Angeles, CA·Twitter for iPhone
👍️0
Nathans123 Nathans123 4 년 전
Come on brady get your thrid party people moving so us longs can finally make some money!!! I though it was supposta be done in February? Covid didnt slow it down either you say..
👍️0
thejourneyman thejourneyman 4 년 전
Some good news today.
👍️0
Nathans123 Nathans123 4 년 전
Got a response from brady via Twitter

Still being put together. See PR last month and report from Zacks earlier this month. I’m as eager as anyone Nathan
6:01 PM · Feb 22, 2021 from Norwalk, CA·Twitter for iPhone
👍️0
Nathans123 Nathans123 4 년 전
I though the app was supposed to be completed the beginning of this month? Brady letting us down again?
👍️0
JB51 JB51 4 년 전
I wish! Have long ways to get back to even
👍️0
Nathans123 Nathans123 4 년 전
We should be popping anytime ladys and gentlemen
👍️0
Admtiger Admtiger 4 년 전
It's been a long time since I checked on this. Is that a good a bad thing?
👍️0
Nathans123 Nathans123 4 년 전
Grant should be up 1-31-21 so we should be getting close to knowing whats up.. Id hope..
👍️0
thejourneyman thejourneyman 4 년 전
Can't say I disagree with you at this point.
👍️0
Kizersosae Kizersosae 4 년 전
Pretty sure all this company does anymore is issue their own directors shares. If yinz remember that’s exactly what I said was going to happen with the RS. People argued with me on here saying, “Brady’s shares will be shortened as well”. Ya but they just issue themselves more shares. Oh well... hope they eventually get through clinical on into them. Be honest I don’t even know where they are at at this point.
👍️0
JB51 JB51 5 년 전
Yes very true, but it all goes back to who’s going to pay ??, still need insurance to step up!
👍️0
Pip611 Pip611 5 년 전
There will be tons of opioid addicts and alcoholics after this Covid mess!
👍️0
JB51 JB51 5 년 전
Would be nice to hear some news!!
👍️0
froggie77 froggie77 5 년 전
Brady -
You’re not getting up-listed. Reverse your reverse split and give those of us who’ve lost $20K+ in value a chance to recoup. This was a good stock when it was in penny land, and clearly the company has no business getting up listed for a few more years, at best...
👍️0
Thirdeyeblind Thirdeyeblind 5 년 전
Did I miss anything?
👍️0
big orange big orange 5 년 전
Do they have any idea when they will bring the compound to market? It seems like they are only surviving because of the grants that bicx has received.
👍️0
thejourneyman thejourneyman 5 년 전
I agree. Looks like Brady answered your question directly with today's update.
👍️0
big orange big orange 5 년 전
Would do a whole lot better if this company could get anything done. Any ideas if and when any clinical trials will begin?
👍️0
thejourneyman thejourneyman 5 년 전
How's everyone doing?
👍️0
GaryWinthorpe GaryWinthorpe 5 년 전
The initial post was about the grant money...nothing else. All the other info you included to indicate "bad news" was already known.
👍️0
drugmanrx drugmanrx 5 년 전
Money is good , what is BAD is that after leading investors to think they were ready to market the implant years ago.

Now they are telling us they haven't even started human trials yet.

Meaning they are years away from a saleable product.

That is not good news at all.

No significant clinical advancement of product no significant raise in share price.

Now how is that good.
👍️0
GaryWinthorpe GaryWinthorpe 5 년 전
My bad...you're right, it's bad news to receive the second half of the grant...
👍️0

최근 히스토리

USOTC
BICX
BioCorRx (QB)
TG
4YC
M3
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유